Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
143.62B
Market cap143.62B
Price-Earnings ratio
51.67
Price-Earnings ratio51.67
Dividend yield
Dividend yield
Average volume
9.62M
Average volume9.62M
High today
$98.35
High today$98.35
Low today
$96.07
Low today$96.07
Open price
$96.46
Open price$96.46
Volume
13.39M
Volume13.39M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $96.88. The company's market cap stands at 143.62B, with a P/E ratio of 51.67.

During the trading session on 2025-11-22, Boston Scientific(BSX) shares reached a daily high of $98.35 and a low of $96.07. At a current price of $96.88, the stock is +0.8% higher than the low and still -1.5% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 13.39M, versus its average volume of 9.62M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

Nasdaq 13h
Boston Scientific Upgraded to Buy: Here's What You Should Know

Boston Scientific (BSX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend...

Boston Scientific Upgraded to Buy: Here's What You Should Know
TipRanks 2d
Boston Scientific Approves 2026 Bonus Plan

TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...

Nasdaq 3d
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. Acco...

BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More BSX News

Simply Wall St 3d
How Investors May Respond To Boston Scientific Securing Exclusive U.S. and Japan Rights for Siemens Catheter

Boston Scientific recently announced a catheter development and commercialization agreement with Siemens Healthineers for the AcuNav 4D intracardiac echocardiog...

How Investors May Respond To Boston Scientific Securing Exclusive U.S. and Japan Rights for Siemens Catheter

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.